Loading...

Omnicell, Inc.

OMCL•NASDAQ
Healthcare
Medical - Healthcare Information Services
$33.08
$-0.54(-1.61%)

Omnicell, Inc. (OMCL) Stock Overview

Explore Omnicell, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.1/100

Key Financials

Market Cap1.5B
P/E Ratio66.77
EPS (TTM)$0.50
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Week$32.09
1 Month$27.97
3 Months$47.68
1 Year Target$24.21

OMCL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Omnicell, Inc. (OMCL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $24.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 66.77 and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.93%
5-Day Change
-5.96%
1-Month Change
-13.52%
3-Month Change
-26.49%
6-Month Change
-26.21%
Year-to-Date (YTD) Change
-29.87%
1-Year Change
13.27%
3-Year Change
-74.57%
5-Year Change
-54.87%
All-Time (Max) Change
254.79%

Contact Information

https://www.omnicell.com
650 251 6100
590 East Middlefield Road, Mountain View, CA, 94043

Company Facts

3,620 Employees
IPO DateAug 9, 2001
CountryUS
Actively Trading

Frequently Asked Questions

;